ReviewsNo Access

Treatment of Nasopharyngeal Carcinoma

Joseph Wee

Department of Therapeutic Radiology, National Cancer Center, Singapore

Correspondence to: Dr. Joseph Wee, Snr Consultant (Radiation Oncology), Director, Division of Clinical Trials & Epidemiological Sciences, National Cancer Centre.

Search for more papers by this author

https://doi.org/10.1142/S0219836303000050Cited by:1 (Source: Crossref)

Abstract

Nasopharyngeal Cancer is a radiosensitive disease. About 60% of all patients are cured with radiotherapy alone, and this figure is likely to increase with the use of chemotherapy. The use of Intensity Modulated Radiotherapy (IMRT) will improve local control and reduce the morbidity of irradiation. Salvage surgery is used for local and regional relapses, but the use of radiosurgery may result in comparable outcomes. In the metastatic setting, the use of new molecules involved in signaling pathways and the use of immunotherapy strategies are being investigated.

Keywords:

References

I. Fleminget al. (eds.), AJCC Cancer Staging Manual, 5th edn. (Lippincott Williams & Wilkins, Philadelphia, PA, 1997) pp. 31–39. Google Scholar
UICC Nasopharyngeal Cancer Conference, Hong Kong, 2003 . Google Scholar
S. H. Nget al., Top Magn. Reson. Imaging 10(5), 290 (1999), DOI: 10.1097/00002142-199910000-00003. Crossref, Google Scholar
C. H. Kao, J. F. Hsieh and S. C. Tsai, Ann. Otol. Rhinol. Laryngol. 109(12 Part 1), 1130 (2000). Crossref, Google Scholar
D. M. Henget al., Cancer 86(10), 1912 (1999). Crossref, Google Scholar
P. Teo, Nasopharyngeal Carcinoma, eds. van Hasselt and A. G. Gibb (The Chinese University Press, Hong Kong, 1991) pp. 169–188. Google Scholar
R. Stanley and K. W. Fong, Nasopharyngeal Carcinoma, eds. V. F. Chong and S. Y. Tsao (Armour Publishing, 1997) pp. 29–41. Google Scholar
R. T. Hoppeet al., Int. J. Radiat. Oncol. Biol. Phys. 4(3–4), 199 (1978). Crossref, Google Scholar
K. Shanmugaratnamet al., Cancer 44(3), 1029 (1979). Crossref, Google Scholar
Enis Özyar, Ferah Yildiz and Fadil H. Akyol, Int. J. Radiat. Oncol. Biol. Phys. 44(5), 1079 (1999). Crossref, Google Scholar
A. W. Leeet al., Int. J. Radiat. Oncol. Biol. Phys. 23(2), 261 (1992). Crossref, Google Scholar
A. W. Leeet al., Br. J. Radiol. 65(778), 918 (1992), DOI: 10.1259/0007-1285-65-778-918. Crossref, Google Scholar
A. W. M. Lee, Nasopharyngeal Carcinoma, eds. van Hasselt and A. G. Gibb (The Chinese University Press, Hong Kong, 1991) pp. 221–234. Google Scholar
K. W. Fonget al., Ann. Acad. Med. Singapore 25(3), 341 (1996). Google Scholar
P. M. Teo, S. F. Leung and J. Fowler, Radiother. Oncol. 57(2), 155 (2000), DOI: 10.1016/S0167-8140(00)00248-6. Crossref, Google Scholar
J. Wee et al. , A review of intracavitary brachytherapy for nasopharyngeal cancer , Proc ASCO . Google Scholar
P. Teo, S. Y. Tsao and W. Shiu, Int. J. Radiat. Oncol. Biol. Phys. 17(3), 515 (1989). Crossref, Google Scholar
S. D. Chang, D. J. Tate and D. R. Goffinet, Stereotact. Funct. Neurosurg. 73(1–4), 64 (1999), DOI: 10.1159/000029753. Crossref, Google Scholar
N. Leeet al., Int. J. Radiat. Oncol. Biol. Phys. 53(1), 12 (2002), DOI: 10.1016/S0360-3016(02)02859-6. Crossref, Google Scholar
M. Cengiz, C. Chao and C. A. Perez, Int. J. Radiat. Oncol. Biol. Phys. 48(3), 323 (2000). Crossref, Google Scholar
S. Wolden et al. , Intensity modulated radiation therapy improves locoregional control for nasopharyngeal carcinoma , Proc ASCO . Google Scholar
C. C. Wang, Cancer 63(12), 2461 (1989). Crossref, Google Scholar
P. M. Teoet al., Int. J. Radiat. Oncol. Biol. Phys. 48(5), 1311 (2000). Crossref, Google Scholar
A. W. Lee, W. M. Sze and T. K. Yau, Radiother. Oncol. 58(2), 121 (2001), DOI: 10.1016/S0167-8140(00)00312-1. Crossref, Google Scholar
Lee AWM, Hong Kong. (Personal Communication) . Google Scholar
J. Weeet al., Review of the 1997 AJCC/UICC Staging System for NPC — The Singapore Experience, 4th International UICC Symposium on Nasopharyngeal Cancer6, J HK Coll Radiol (2003) p. 40. Google Scholar
M. Al-Sarraf et al. , Superiority of five year survival with chemo-radiotherapy (CT-RT) versus radiotherapy in patients (Pts) with locally advanced nasopharyngeal cancer (NPC). Intergroup (0099) (SWOG 8892, RTOG 8817, ECOG 2388) Phase III Study: Final Report , Proc ASCO . Google Scholar
J. C. Linet al., J. Clin. Oncol. 21(4), 631 (2003), DOI: 10.1200/JCO.2003.06.158. Crossref, Google Scholar
A. T. Chanet al., J. Clin. Oncol. 20(8), 2038 (2002), DOI: 10.1200/JCO.2002.08.149. Crossref, Google Scholar
D. L. Kwong, J. S. Sham and G. K. Au, Int. J. Radiat. Oncol. Biol. Phys. 51(3), 42 (2001). Crossref, Google Scholar
Wee J, Singapore. (Personal Communication) . Google Scholar
Lee AWM, Hong Kong. (Personal Communication) . Google Scholar
M. Huncharek and B. Kupelnick, Am. J. Clin. Oncol. 25(3), 219 (2002), DOI: 10.1097/00000421-200206000-00002. Crossref, Google Scholar
S. H. Chenget al., Int. J. Radiat. Oncol. Biol. Phys. 48(5), 1323 (2000). Crossref, Google Scholar
R. L. Honget al., J. Clin. Oncol. 19(23), 4305 (2001). Crossref, Google Scholar
Arlene A. Forastiere et al. , Phase III trial to preserve the larynx: Induction chemo-therapy and radiotherapy versus concomitant chemo-radiotherapy versus radiotherapy alone, Intergroup Trial R91-11 , Proc ASCO . Google Scholar
J. P. Pignonet al., Lancet 355(9208), 949 (2000). Crossref, Google Scholar
International Nasopharynx Cancer Study GroupInt. J. Radiat. Oncol. Biol. Phys. 35(3), 463 (1996). Crossref, Google Scholar
A. T. Chanet al., Int. J. Radiat. Oncol. Biol. Phys. 33(3), 569 (1995). Crossref, Google Scholar
D. T. Chuaet al., Cancer 83(11), 2270 (1998). Crossref, Google Scholar
J. Maet al., J. Clin. Oncol. 19(5), 1350 (2001). Crossref, Google Scholar
L. J. Peters and H. R. Withers, Int. J. Radiat. Oncol. Biol. Phys. 39(4), 831 (1997). Crossref, Google Scholar
A. J. Davis and J. F. Tannock, Lancet Oncol. 1, 86 (2000), DOI: 10.1016/S1470-2045(00)00019-X. Crossref, Google Scholar
L. Milaset al., Radiother. Oncol. 30(3), 247 (1994), DOI: 10.1016/0167-8140(94)90465-0. Crossref, Google Scholar
J. Bourhiset al., Laryngoscope 104(4), 468 (1994), DOI: 10.1288/00005537-199404000-00012. Crossref, Google Scholar
Peter I. Clark, Ann. Oncol. 11(4), 4 (2000). Crossref, Google Scholar
Lesley A. Stewart and Jayne F. Tierney , Neoadjuvant chemotherapy and surgery versus standard radiotherapy for locally advanced cervix cancer: A meta-analysis using individual patient data from randomised controlled trials (RCTs) , Proc ASCO . Google Scholar
A. Depierre, B. Milleron and D. Moro-Sibilot, J. Clin. Oncol. 20(1), 247 (2002), DOI: 10.1200/JCO.20.1.247. Crossref, Google Scholar
R. B. Natale et al. , SWOG 8710 (INT-0080): Randomized phase III trial of neoadjuvant MVAC + cystectomy versus cystectomy alone in patients with locally advanced bladder cancer , Proc ASCO . Google Scholar
R. O. Dillmanet al., J. Natl. Cancer Inst. 88(17), 1210 (1996). Crossref, Google Scholar
D. Rischinet al., J. Clin. Oncol. 20(7), 1845 (2002), DOI: 10.1200/JCO.2002.07.011. Crossref, Google Scholar
J. L. Ohet al., Ann. Oncol. 14(4), 564 (2003), DOI: 10.1093/annonc/mdg163. Crossref, Google Scholar
A. Lee et al. , Encouraging early results for advanced stage III-IV nasopharyngeal carcinoma using neoadjuvant-concurrent chemotherapy and accelerated radiotherapy , Proc ASTRO . Google Scholar
A. T. Chan et al. , A phase II study (NPC001) of neoadjuvant taxol and carboplatin followed by concurrent cisplatin-radiotherapy in locoregionally advanced nasopharyngeal carcinoma (NPC) with EBVDNA monitoring , Proc ASCO . Google Scholar
Eschwege F, France. (Personal Communication) . Google Scholar
W. I. Weiet al., Arch. Otolaryngol. Head Neck Surg. 121(6), 638 (1995). Crossref, Google Scholar
W. E. Feeet al., Arch. Otolaryngol. Head Neck Surg. 128(3), 280 (2002). Google Scholar
W. W. Kinget al., Head Neck 22(3), 215 (2000). Crossref, Google Scholar
M. M. Hsuet al., Arch. Otolaryngol. Head Neck Surg. 127(7), 798 (2001). Google Scholar
A. W. Leeet al., Int. J. Radiat. Oncol. Biol. Phys. 38(1), 43 (1997). Crossref, Google Scholar
J. M. Hwang, K. K. Fu and T. L. Phillips, Int. J. Radiat. Oncol. Biol. Phys. 41(5), 1099 (1998). Crossref, Google Scholar
C. C. Wang, Int. J. Radiat. Oncol. Biol. Phys. 13(7), 953 (1987). Crossref, Google Scholar
D. Choyet al., Int. J. Radiat. Oncol. Biol. Phys. 25(3), 505 (1993). Crossref, Google Scholar
D. T. Chuaet al., Head Neck 23(9), 791 (2001), DOI: 10.1002/hed.1113. Crossref, Google Scholar
P. C. Paiet al., Head Neck 24(8), 748 (2002), DOI: 10.1002/hed.10116. Crossref, Google Scholar
E. T. Chua , Radiosurgery , UICC Workshop on Nasopharyngeal Cancer . Google Scholar
J. Xiao, G. Xu and Y. Miao, Int. J. Radiat. Oncol. Biol. Phys. 51(1), 164 (2001). Crossref, Google Scholar
M. L. Khooet al., Aust. N. Z. J. Surg. 69(5), 354 (1999), DOI: 10.1046/j.1440-1622.1999.01571.x. Crossref, Google Scholar
W. I. Weiet al., Arch. Otolaryngol. Head Neck Surg. 118(9), 923 (1992). Crossref, Google Scholar
J. S. Sham and D. Choy, Australas Radiol. 35(4), 370 (1991), DOI: 10.1111/j.1440-1673.1991.tb03050.x. Crossref, Google Scholar
L. C. Cheng, J. S. Sham and C. S. Chiu, Aust. N. Z. J. Surg. 66(2), 71 (1996), DOI: 10.1111/j.1445-2197.1996.tb01114.x. Crossref, Google Scholar
E. Au and P. T. Ang, Ann. Oncol. 5(1), 87 (1994). Crossref, Google Scholar
T. L. Wang and Y. O. Tan, Ann. Acad. Med. Singapore 20(5), 601 (1991). Google Scholar
E. H. Tanet al., Ann. Oncol. 10(2), 235 (1999), DOI: 10.1023/A:1008390929826. Crossref, Google Scholar
R. K. Nganet al., Ann. Oncol. 13(8), 1252 (2002), DOI: 10.1093/annonc/mdf200. Crossref, Google Scholar
S. S. Leong et al. , Phase II study of Gemcitabine, Paclitaxel, and Carboplatin in patients with metastatic nasopharyngeal carcinoma (NPC) — Updated results , Proc ASCO . Google Scholar
R. L. Honget al., Br. J. Cancer 80(12), 1962 (1999), DOI: 10.1038/sj.bjc.6690627. Crossref, Google Scholar
A. Fandi, M. Bachouchi and N. Azli, J. Clin. Oncol. 18(6), 1324 (2000). Crossref, Google Scholar
L. L. Siu, P. M. Czaykowski and I. F. Tannock, J. Clin. Oncol. 16(7), 2514 (1998). Crossref, Google Scholar
A. T. Chan et al. , Cancer Therapeutics Research Group. A Phase II study of cetuximab (C225) in combination with carboplatin in patients (pts) with recurrent or metastatic nasopharyngeal carcinoma (NPC) who failed to a platinum-based chemotherapy , Proc ASCO . Google Scholar
K. S. Tan and W. S. Loh , COX-2 overexpression in nasopharyngeal cancer , Proc AAO-HNSF . Google Scholar
R. Khannaet al., Trends Mol. Med. 7(6), 270 (2001), DOI: 10.1016/S1471-4914(01)02002-0. Crossref, Google Scholar
Y. M. Lo, Ann. N. Y. Acad. Sci. 945, 68 (2001), DOI: 10.1111/j.1749-6632.2001.tb03865.x. Crossref, Google Scholar

Vol. 01, No. 01

Metrics

Downloaded 3 times

History

Keywords

PDF download

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Treatment of Nasopharyngeal Carcinoma

Abstract

Recommended